Mindpeak Welcomes Christiaan Neeleman to the Board of Directors

We are delighted to announce that Christiaan Neeleman has joined Mindpeak’s Board of Directors.
With more than 20 years of international leadership experience in life sciences, diagnostics, and health technology - including senior roles at Discovery Life Sciences, Definiens, and Philips Healthcare - Christiaan brings deep expertise that will help accelerate our global expansion.
His proven track record in biomarker development, companion diagnostics, and scaling precision diagnostics businesses aligns perfectly with Mindpeak’s mission: enabling faster, more accurate cancer diagnostics through AI-powered pathology.
We are excited to collaborate with Christiaan as we strengthen partnerships, expand into new markets, and further drive the adoption of AI across clinical and research settings.
Read the full press release here
You may also be interested in
Find out more about our AI-based diagnostics
